1. Home
  2. VRA vs ABOS Comparison

VRA vs ABOS Comparison

Compare VRA & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.27

Market Cap

60.6M

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.11

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
ABOS
Founded
1982
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
113.9M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
VRA
ABOS
Price
$2.27
$2.11
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$4.00
$7.67
AVG Volume (30 Days)
1.1M
157.6K
Earning Date
12-11-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$324,296,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$0.86
52 Week High
$4.09
$2.46

Technical Indicators

Market Signals
Indicator
VRA
ABOS
Relative Strength Index (RSI) 48.06 55.67
Support Level $2.25 $2.01
Resistance Level $2.50 $2.39
Average True Range (ATR) 0.19 0.13
MACD 0.02 0.02
Stochastic Oscillator 75.49 50.93

Price Performance

Historical Comparison
VRA
ABOS

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: